Herantis Pharma’s Manager’s Transactions

Herantis Pharma’s Manager’s Transactions

Herantis Pharma Plc
Company release 2 Jan 2017 at 9:00 am

Herantis Pharma Oyj – Managers’ Transactions

____________________________________________

Person subject to the notification requirement

Name: Meles Consulting Oy, Controlled company of Pekka Simula

Position: Chief Executive Officer

(X) Legal person

Issuer: Herantis Pharma Oyj

LEI: 743700W4CQVYAT3WKK38

Notification type: INITIAL NOTIFICATION

Reference number: 743700W4CQVYAT3WKK38_20161230145023_1

____________________________________________

Transaction date: 2016-12-30

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000087861

Nature of the transaction: ACQUISITION

Transaction Details

(1): Volume: 1000 Unit price: 3,00000 EUR

Aggregated transactions

(1): Volume: 1000 Volume weighted average price: 3.00000 EUR

Further information:

Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 25 380 246

Distribution:

Nasdaq Helsinki
Main media
www.herantis.com